Kennestone Cancer Center at Wellstar Kennestone Hospital
Marietta, Georgia, United States
Medical clinic in Marietta, Georgia
340 Kennestone Hospital Blvd, Marietta, GA 30060
About Kennestone Cancer Center at Wellstar Kennestone Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
SWOG Cancer Research Network
28
SCRI Development Innovations, LLC
13
Alliance for Clinical Trials in Oncology
8
NSABP Foundation Inc
6
ECOG-ACRIN Cancer Research Group
2
Eastern Cooperative Oncology Group
2
Mayo Clinic
1
Radiation Therapy Oncology Group
1
Clinical Trials at Kennestone Cancer Center at Wellstar Kennestone Hospital
During the past decade, Kennestone Cancer Center at Wellstar Kennestone Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 26 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
2001-09-01
2012-11-01
Completed
183
S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
2002-06-01
2015-10-01
Completed
147
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
2002-11-01
2009-12-01
Completed
671
EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
2002-12-01
2015-04-01
Completed
226
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kennestone Cancer Center at Wellstar Kennestone Hospital" #1 sponsor was "SWOG Cancer Research Network" with 28 trials, followed by "SCRI Development Innovations, LLC" with 13 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 6 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kennestone Cancer Center at Wellstar Kennestone Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "Genentech, Inc." with 8 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 24 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at Kennestone Cancer Center at Wellstar Kennestone Hospital
According to Clinical.Site data, the most researched conditions in "Kennestone Cancer Center at Wellstar Kennestone Hospital" are
"Breast Cancer" (15 trials), "Lung Cancer" (11 trials), "Lymphoma" (7 trials), "Colorectal Cancer" (5 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "Kennestone Cancer Center at Wellstar Kennestone Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kennestone Cancer Center at Wellstar Kennestone Hospital
Most popular intervention types in "Kennestone Cancer Center at Wellstar Kennestone Hospital" are "Drug" (45 trials), "Other" (21 trials), "Biological" (13 trials), "Radiation" (11 trials) and "Procedure" (7 trials). Other intervention types were less common.
The name of intervention was led by "bevacizumab" (7 trials), "cyclophosphamide" (7 trials), "placebo" (7 trials), "Bevacizumab" (6 trials) and "biologic sample preservation procedure" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Kennestone Cancer Center at Wellstar Kennestone Hospital
The vast majority of trials in "Kennestone Cancer Center at Wellstar Kennestone Hospital" are
48 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Kennestone Cancer Center at Wellstar Kennestone Hospital
Currently, there are NaN active trials in "Kennestone Cancer Center at Wellstar Kennestone Hospital".
undefined are not yet recruiting,
undefined are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 53 completed trials in Kennestone Cancer Center at Wellstar Kennestone Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Kennestone Cancer Center at Wellstar Kennestone Hospital, 2 "Phase 1"
clinical trials were conducted, 27 "Phase 2" clinical
trials and 22 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".